Job Description
Airtree recently invested in an early stage biologics company. Currently in stealth, they exist to make biologics radically cheaper, so modern medicine reaches the people today's industry prices out, across both human and animal health.
The Company
Discovery got cheap; manufacturing didn’t. The cost of making biologics is now one of the biggest constraints keeping modern medicines from patients.
That is the constraint we exist to break.
We are building factories that deliver a 20–50x cost reduction at scale: more than 10 tonnes of drug substance a year, at under $10 a gram. Think of it as a foundry: a standardised manufacturing platform that molecules adapt to, rather than a contract manufacturer running a bespoke process for every client.
Our founding team has built a version of this before. We are now applying the same engineering playbook to biologics: standardise the hard parts, learn faster than everyone else, and make the economics ...